Transgene Biotek Ltd

1)The Board considered and approved the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter ended 30th June 2025. 2)The Board considered and approved the Limited Review Report (Standalone & Consolidated) of the Company for the quarter ended 30th June 2025. 3)The Board considered and approved the extension of the date of Annual General Meeting (AGM) of the Company for the financial year 2024-25.4)The Board considered and approved the appointment of M/s.Manisha Dubey & Associates as Internal Auditors of the Company for the financial year 2025-26. 5)The Board considered and approved the appointment of M/s. Geeta Serwani & Associates Practicing Company Secretaries as Secretarial Auditor of the Company for the term of 5 years effective from 01st April 2025 till 31st March 2030 which is subject to regularization by shareholders at AGM; The meeting commenced at 11.00 A.M and concluded at 11.45A.M.